Assertio (ASRT) shares ended the last trading session 17% higher at $21.61. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

Assertio Holdings said on Monday that Garda Therapeutics has raised its all-cash tender offer to $21.80 per share, valuing the drugmaker at about $153.2M. Shares jumped 17% in ear ...

The modelled fair value for Assertio Holdings sits at US$21.33 per share, with no adjustment to the central price target in the latest update. This stable target reflects how recent analyst commentary ...

The average one-year price target for Assertio Holdings (NasdaqCM:ASRT) has been revised to $27.80 / share. This is a ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Assertio (ASRT) one of those stocks right now? Let's take a ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Assertio (ASRT) is a stock that can certainly grab the attention ...